UNSPSC 51284002: Chlortetracycline

This classification denotes a tetracycline antibiotic with the molecular formula C22H23ClN2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WCK1KIQ23Q, chemically known as 2-(amino-hydroxy-methylidene)-7-chloro-4-dimethylamino-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione but generally known as chlortetracycline, which bears US NIH Compound Identifier 5280963.

UNSPSC 51284002 Chlortetracycline is a Commodity-tier code nominally for a specific antibiotic product, but recent state and local opportunities tagged under it show no procurement activity actually aligned with chlortetracycline itself. Instead, the code carries a mix of health and pharmacy-related solicitations spanning naloxone supply, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic pharmaceutical distribution through cooperative purchasing. The actual buying under this code label reflects broader health-supply and pharmacy-benefit procurement rather than the narrow antibiotic commodity the code name suggests, indicating either a tagging error in the posting systems or a catch-all use of the code for multi-product pharmacy and medical supply categories.

Recent activity shows issuing bodies ranging across county health departments, state health and human services commissions, municipal fire departments, and multistate cooperative purchasing alliances. Seminole County, Florida released an IFB on June 30, 2026 for naloxone and drug deactivation systems with a July 26, 2023 response date; the City of Tampa issued an IFB (26P00145) on March 25, 2026 for medical and first aid supplies for its Fire Department Rescue Division, estimated at $700,000 with a Small Local Business Enterprise set-aside and 5 percent bid discount; the Texas Health and Human Services Commission posted an RFI on April 3, 2026 regarding direct-to-manufacturer prescription fulfillment; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, requiring products to be available by May 15, 2026 and contracts effective July 1, 2026. Geographic activity spans Florida, Texas, Minnesota, and participating cooperative members including Oregon. This code shows inconsistent tagging that conflates pharmaceutical manufacturing, health-supply distribution, and pharmacy-benefit management rather than discrete procurement of chlortetracycline itself.